Subtopic Deep Dive

Passiflora incarnata for Anxiety Disorders
Research Guide

What is Passiflora incarnata for Anxiety Disorders?

Passiflora incarnata extracts are investigated in clinical trials and reviews for their anxiolytic effects via GABAergic modulation as alternatives to benzodiazepines in treating generalized anxiety disorder.

Systematic reviews like Lakhan and Vieira (2010) with 178 citations analyze herbal supplements including Passiflora incarnata for anxiety relief without serious side effects. Recent works such as Bruni et al. (2021) with 95 citations explore its impact on GABAergic systems and sleep disturbances linked to anxiety. Over 10 papers from 2010-2023 cover pharmacological mechanisms and efficacy comparisons.

15
Curated Papers
3
Key Challenges

Why It Matters

Passiflora incarnata offers evidence-based natural options for anxiety amid rising synthetic drug side effects, as Lakhan and Vieira (2010) report effective supplementation without addiction risks. Sarris et al. (2012) highlight its role in complementary therapies reducing reliance on pharmaceuticals for GAD patients. Alramadhan et al. (2012) note its neurotransmitter restoration versus manipulative anxiolytics, supporting safer long-term use in stress-related conditions.

Key Research Challenges

Standardized Extract Variability

Passiflora incarnata extracts vary in flavonoid content affecting reproducibility, as noted in Villarreal et al. (2012). Clinical trials lack uniform dosing, complicating efficacy comparisons (Lakhan and Vieira, 2010). Standardization protocols remain inconsistent across studies.

Limited Large-Scale RCTs

Most evidence relies on small trials rather than large RCTs, per Sarris et al. (2012) review of 92 citations. Long-term safety data for chronic anxiety use is scarce (Bruni et al., 2021). High-quality trials versus benzodiazepines are needed.

GABA Mechanism Elucidation

Exact GABAergic modulation pathways need clarification beyond preliminary findings in Bruni et al. (2021). Interactions with other neurotransmitters are underexplored (Alramadhan et al., 2012). Molecular studies lag behind clinical observations.

Essential Papers

1.

Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review

Shaheen E Lakhan, Karen Vieira · 2010 · Nutrition Journal · 178 citations

Based on the available evidence, it appears that nutritional and herbal supplementation is an effective method for treating anxiety and anxiety-related conditions without the risk of serious side e...

2.

Herbal Remedies and Their Possible Effect on the GABAergic System and Sleep

Oliviero Bruni, Luigi Ferini‐Strambi, Elena Giacomoni et al. · 2021 · Nutrients · 95 citations

Sleep is an essential component of physical and emotional well-being, and lack, or disruption, of sleep due to insomnia is a highly prevalent problem. The interest in complementary and alternative ...

3.

Complementary Medicine, Exercise, Meditation, Diet, and Lifestyle Modification for Anxiety Disorders: A Review of Current Evidence

Jerome Sarris, Steven Moylan, David Camfield et al. · 2012 · Evidence-based Complementary and Alternative Medicine · 92 citations

Use of complementary medicines and therapies (CAM) and modification of lifestyle factors such as physical activity, exercise, and diet are being increasingly considered as potential therapeutic opt...

4.

Medicinal Plants for Insomnia Related to Anxiety: An Updated Review

Silvia Borrás, Isabel Martínez‐Solís, José Luis Rı́os · 2021 · Planta Medica · 58 citations

Abstract Sleep disorders are common among the general population and can generate health problems such as insomnia and anxiety. In addition to standard drugs and psychological interventions, there ...

5.

Natural Product-Derived Treatments for Attention-Deficit/Hyperactivity Disorder: Safety, Efficacy, and Therapeutic Potential of Combination Therapy

James Ahn, Hyung Seok Ahn, Jae Hoon Cheong et al. · 2016 · Neural Plasticity · 30 citations

Typical treatment plans for attention-deficit/hyperactivity disorder (ADHD) utilize nonpharmacological (behavioral/psychosocial) and/or pharmacological interventions. Limited accessibility to behav...

6.

Dietary and botanical anxiolytics

Elham Alramadhan, Mirna S. Hanna, Mena S. Hanna et al. · 2012 · Medical Science Monitor · 22 citations

Drugs used to treat anxiety have many negative side effects including addiction, depression, suicide, seizures, sexual dysfunction, headaches and more. Anxiolytic medications do not restore normal ...

7.

Plants Alkaloids Based Compound as Therapeutic Potential for Neurodegenerative

Rajnish Kumar Patel, Dushyant Gangwar, Harshul Gupta et al. · 2023 · Journal for Research in Applied Sciences and Biotechnology · 15 citations

Although while getting a restful night's sleep is essential for your mental and physical health, insomnia is very prevalent. More people are turning to complementary and alternative therapies to tr...

Reading Guide

Foundational Papers

Start with Lakhan and Vieira (2010, 178 citations) for systematic evidence overview, then Sarris et al. (2012, 92 citations) for CAM comparisons, and Alramadhan et al. (2012) for mechanisms.

Recent Advances

Study Bruni et al. (2021, 95 citations) for GABA/sleep links, Borrás et al. (2021, 58 citations) for insomnia-anxiety plants, and Patel et al. (2023) for alkaloids.

Core Methods

RCTs with Hamilton Anxiety Rating Scale (Lakhan 2010), GABA binding assays (Bruni 2021), and systematic reviews of pharmacological/clinical data (Villarreal 2012).

How PapersFlow Helps You Research Passiflora incarnata for Anxiety Disorders

Discover & Search

PapersFlow's Research Agent uses searchPapers and exaSearch to find Passiflora incarnata trials, then citationGraph on Lakhan and Vieira (2010) reveals 178-cited connections to GABA studies, while findSimilarPapers uncovers related extracts like those in Bruni et al. (2021).

Analyze & Verify

Analysis Agent applies readPaperContent to extract trial data from Sarris et al. (2012), verifies claims with CoVe chain-of-verification against abstracts, and runs PythonAnalysis to meta-analyze effect sizes across 10 papers using GRADE for evidence grading on anxiolytic efficacy.

Synthesize & Write

Synthesis Agent detects gaps in long-term safety via contradiction flagging between Alramadhan et al. (2012) and recent reviews, while Writing Agent uses latexEditText, latexSyncCitations for Lakhan (2010), and latexCompile to generate trial comparison tables with exportMermaid for GABA pathway diagrams.

Use Cases

"Run meta-analysis on Passiflora incarnata RCTs for GAD effect sizes"

Research Agent → searchPapers('Passiflora incarnata anxiety RCT') → Analysis Agent → readPaperContent(Lakhan 2010) + runPythonAnalysis(pandas meta-analysis) → GRADE-graded effect size CSV export.

"Draft LaTeX review section comparing Passiflora to benzodiazepines"

Synthesis Agent → gap detection(Sarris 2012) → Writing Agent → latexEditText('anxiolytic comparison') + latexSyncCitations(10 papers) + latexCompile → polished PDF section with figures.

"Find code for Passiflora flavonoid extraction simulations"

Research Agent → paperExtractUrls(Bruni 2021) → Code Discovery → paperFindGithubRepo + githubRepoInspect → Python sandbox code for GABA binding models.

Automated Workflows

Deep Research workflow scans 50+ papers via searchPapers on 'Passiflora incarnata anxiety', structures systematic review report with GRADE grading from Lakhan (2010). DeepScan applies 7-step CoVe to verify mechanisms in Bruni et al. (2021), checkpointing against Villarreal (2012). Theorizer generates hypotheses on flavonoid-GABA links from Sarris (2012) citations.

Frequently Asked Questions

What defines Passiflora incarnata research for anxiety?

Studies focus on clinical trials, reviews, and GABA modulation for GAD treatment, as defined in Lakhan and Vieira (2010) systematic review.

What methods test Passiflora incarnata efficacy?

RCTs and pharmacological assays compare it to benzodiazepines, per Sarris et al. (2012); GABA receptor binding in Bruni et al. (2021).

What are key papers on this topic?

Lakhan and Vieira (2010, 178 citations) leads; Bruni et al. (2021, 95 citations) on GABA/sleep; Alramadhan et al. (2012) on botanicals.

What open problems exist?

Lack of large RCTs, extract standardization, and long-term safety data persist, as flagged in Villarreal et al. (2012) and Borrás et al. (2021).

Research Medicinal Plant Extracts Effects with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Passiflora incarnata for Anxiety Disorders with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers